CLOs on the Move

Jounce Therapeutics

www.jouncetx.com

 
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.jouncetx.com
  • 1030 Massachusetts Avenue
    Cambridge, MA USA 02138
  • Phone: 857.259.3840

Executives

Name Title Contact Details

Similar Companies

Medical Imaging Of Teaneck

Medical Imaging Of Teaneck is a Teaneck, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

Foundation Laboratories

Foundation Laboratories is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

United Clinical Laboratories

United Clinical Laboratories is a Dubuque, IA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Mason Dental Lab

Mason Dental Lab is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.